# Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

> **NCT00176033** · — · COMPLETED · sponsor: **Heidelberg University** · enrollment: 12 (estimated)

## Conditions studied

- Healthy
- Pharmacokinetics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00176033
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176033, "Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00176033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*